Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin CEO Interview, Healthcare Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

 

 

 

 

 

 

 

 

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra's Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck

This content is available to members only.

If you are an existing member, please LOGIN

Not a member? Sign up for a FREE trial account now ($49 per month value), and get immediate access.

Register New Account

Free Membership

.

Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2
subscribe@wallstreetreporter.com.




Related Articles

Healthcare

CytoDyn (OTC: CYDY) and Samsung BioLogics Formalize Manufacturing Partnership

May 30, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) and Samsung BioLogics Formalize Manufacturing Partnership

INCHEON, South Korea, May 30, 2019 – CytoDyn Inc., (OTC: CYDY) a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications and Samsung BioLogics met at […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
Healthcare

Hoth Therapeutics (NASDAQ: HOTH) to Present at the H.C. Wainwright 21st Annual Global Investment Conference and RESI 2019 Boston Conference

September 6, 2019 admin Healthcare, Newsmakers Comments Off on Hoth Therapeutics (NASDAQ: HOTH) to Present at the H.C. Wainwright 21st Annual Global Investment Conference and RESI 2019 Boston Conference

NEW YORK, Sept. 6, 2019  — Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
Healthcare

CytoDyn (OTC: CYDY) Files Pivotal Trial Protocol for HIV Monotherapy with FDA

May 20, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) Files Pivotal Trial Protocol for HIV Monotherapy with FDA

VANCOUVER, Washington, May 15, 2019 — After four years of monotherapy trials, data is now available to submit the long-anticipated pivotal trial for monotherapy to the FDA Trial will include 10 weeks of induction therapy […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati